Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Betterlife Pharma Inc
(CSE:
BETR
)
0.0500
UNCHANGED
Streaming Delayed Price
Updated: 1:13 PM EST, Dec 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0500
Bid (Size)
0.0450 (132,000)
Ask (Size)
0.0500 (89,000)
Prev. Close
0.0500
Today's Range
0.0500 - 0.0500
52wk Range
0.0450 - 0.1750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
May 28, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
May 22, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Performance
YTD
-54.5%
-54.5%
1 Month
N/A
N/A
3 Month
-41.2%
-41.2%
6 Month
-47.4%
-47.4%
1 Year
-52.4%
-52.4%
More News
Read More
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 14, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Debt Settlements
May 06, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Microcap Stocks to Watch: STSS, AGMH, FMTO, SUNE, Signal Strength Amid Market Volatility – More Picks Inside
April 10, 2025
Via
AB Newswire
Topics
Artificial Intelligence
BetterLife Pharma Appoints Corporate Advisor
April 03, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Pharma Appoints New Director
March 31, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Debt Conversions
March 10, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent
January 14, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Favorable Outcome in New York Legal Claims
December 09, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001
November 25, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001
October 23, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Fully Subscribed Private Placement Financing
August 29, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent
August 27, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
July 02, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
June 26, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
June 14, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
May 14, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Intent to Complete Private Placement of Units
May 03, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Advances BETR-001 IND-enabling Studies
May 01, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 11, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
April 03, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
January 02, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University
March 04, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
December 18, 2023
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Betterlife Pharma Inc publicly traded?
Yes, Betterlife Pharma Inc is publicly traded.
What exchange does Betterlife Pharma Inc trade on?
Betterlife Pharma Inc trades on the Canadian Securities Exchange
What is the ticker symbol for Betterlife Pharma Inc?
The ticker symbol for Betterlife Pharma Inc is BETR on the Canadian Securities Exchange
What is the current price of Betterlife Pharma Inc?
The current price of Betterlife Pharma Inc is 0.0500
When was Betterlife Pharma Inc last traded?
The last trade of Betterlife Pharma Inc was at 12/18/25 01:13 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today